MedPath

Role of shirishaswagandhadiavleha and anutail nasya in the management of vataj pratishyay- Allergic rhinities.

Phase 2
Completed
Conditions
Allergic rhinitis, unspecified,
Registration Number
CTRI/2019/01/017243
Lead Sponsor
IPGT and RA GAU Jamnagar
Brief Summary

The trial is randomized clinical trial to evaluate the efficacy of shirishaswagandhadiavleha ashwagandhadi avaleha with and without anutail nasya in the management of Allergic rhinitis- vataja pratishyay.Total 30 patients will be enrolled in the study.selected patients will be divided into two groups on the basis of computer generated randomization.In this study shirishaswagandhadiavleha ashwagandhadi avleha will be given in dose of 10 gms twice a day after meal with Luke warm water for one month with anutaila Marsh nasya 6 to 10 drops each nostrils 3 sitting of 7 days.In another group only shirisha ashwagandhadi avleha will be given  in dose of 10 gms twice a day after meal with Luke warm for 1 month.follow up will be carried out at 15 days interval for one month on routin medicine.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Patients fulfilling the diagnostic criteria based on signs and symptoms of Vataja Pratishyaya (Allergic Rhinitis) in Ayurvedic classics and modern science will be selected for the present study.
  • According to the Ayurvedic view: a.Aanadhdha Pihita Nasa b.Tanu Strava c.Gala Talu Austha Shosha d.Nistoda Sankhayo e.Svaropa Ghata According to the Modern view: SYMPTOMS a.Sneezing b.Nasal discharge c.Nasal blockage d.Headache/heaviness of head e.Itching in Nose, Eyes, Throat, Palate SIGNS f."Allergic shiners" g."Nasal crease" (allergic salute).
  • h.Swollen (boggy), pale, blue-gray nasal mucosa 2.Patients between the ages of 18 to 50 years of irrespective Sex Religion and Caste.
  • 3.Patient willing and able to participate.
Exclusion Criteria
  • Below 18 and Above 50yr,surgical intervention like nasal polyp,T.B,D.M,Asthma and other respiratory diseases.
  • Pregnant ladies and lactating mothers.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Relief in signs and symptoms of vataja pratishyay for 30 days of trialdrug.Relief in signs and symptoms of vataja pratishyay for 30 days of trialdrug.
Secondary Outcome Measures
NameTimeMethod
Relief in signs and symptoms of vataja pratishyay for 30days of trialdrugRelief in signs and symptoms of vataja pratishyay for 30days of trialdrug

Trial Locations

Locations (1)

PG hospital IPGT and RA, Jamnagar

🇮🇳

Jamnagar, GUJARAT, India

PG hospital IPGT and RA, Jamnagar
🇮🇳Jamnagar, GUJARAT, India
bhagyashree potdar
Principal investigator
9427765159
bkpotdar1993@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.